11127767

Nawroth F

2000

[The significance of leptin for reproduction].

11133068

Ib??ez L

2000

Premature adrenarche--normal variant or forerunner of adult disease?

11133670

Henmi H

2001

Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats.

11134093

Urbanek M

2000

Allelic variants of the follistatin gene in polycystic ovary syndrome.

11139533

Falsetti L

2001

Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome.

11139543

Tozer AJ

2001

Does laparoscopic ovarian diathermy affect the outcome of IVF-embryo transfer in women with polycystic ovarian syndrome? A retrospective comparative study.

11139559

Uhler ML

2001

Perforated duodenal ulcer associated with ovarian hyperstimulation syndrome: Case Report.

11139721

Hopkins F

2000

A propos de l'article: le syndrome des ovaries polymicrokystiques par P. Dewailly. J. Gynecol Obstet Biol Reprod 2000, 29, 298-301. [Apropos of the article: Polymicrocystic ovary syndrome by P. Dewailly. J. Gynecol Obstet Biol Reprod 2000, 29, 298-301].

11141339

Hazzard TM

2000

Angiogenesis in ovarian follicular and luteal development.

11141596

Orzeck EA

2000

Ovarian dysmetabolic syndrome.

11147788

Moore GE

2001

Evidence that insulin is imprinted in the human yolk sac.

11148510

Lewy VD

2001

Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.

11148849

Pellicano M

2000

[Ovarian drilling in minilaroscopy and local anesthesia in the therapy of polycystic ovarian syndrome].

11149629

Meyer MF

2000

Association of polycystic ovary syndrome with an interstitial deletion of the long arm of chromosome 11.

11150875

Ciotta L

2001

Endocrine and metabolic effects of insulin sensitizers in the treatment of patients with polycystic ovary syndrome and hyperinsulinaemia.

11153260

Kashyap S

2000

Polycystic ovary disease and the risk of pregnancy-induced hypertension.

11153345

Marasco L

2000

Polycystic ovary syndrome: a connection to insufficient milk supply?

11157811

Mikola M

2001

Obstetric outcome in women with polycystic ovarian syndrome.

11157814

Sir-Petermann T

2001

Secretory pattern of leptin and LH during lactational amenorrhoea in breastfeeding normal and polycystic ovarian syndrome women.

11158002

Vgontzas AN

2001

Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance.

11160560

Kahn SE

2001

Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity.

11160786

Dunaif A

2001

Current concepts in the polycystic ovary syndrome.

11161134

Armstrong VL

2001

Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate.

11163815

Glueck CJ

2001

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study.

11163816

Kahsar-Miller MD

2001

Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.

11163840

Takakura K

2001

Follicle-stimulating hormone receptor gene mutations are rare in Japanese women with premature ovarian failure and polycystic ovary syndrome.

11165733

El-Sheikh MM

2001

Limited ovarian stimulation (LOS), prevents the recurrence of severe forms of ovarian hyperstimulation syndrome in polycystic ovarian disease.

11172636

Mao W

2001

[Study on the mode of inheritance for familial polycystic ovary syndrome].

11172831

Mitwally MF

2001

Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate.

11172832

Vandermolen DT

2001

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone.

11173749

Bazot M

2000

[Ovarian functional disorders].

11183186

Liede A

2000

Delineation of a new syndrome: clustering of pyloric stenosis, endometriosis, and breast cancer in two families.

11185467

Unl?hizarci K

2000

Insulin-sensitizing agents and their effect on adrenal androgens.

11186218

Bray GA

2000

Clinical evaluation of the overweight patient.

11187421

Parulkar AA

2001

Nonhypoglycemic effects of thiazolidinediones.

11189960

D'Amelio R

2000

[Incidence of fibrocystic disease of the breast in women with polycystic ovary. Clinico-instrumental study].

11200929

Yoshimura Y

2000

Clinical implications of insulin-like growth factors and their binding proteins in reproduction.

11202214

Arslanian SA

2000

Type 2 diabetes mellitus in children: pathophysiology and risk factors.

11204367

Falcone T

2001

What the internist needs to know about infertility.

11209536

Balasch J

2000

Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.

11209548

Botella Llusi? J

2000

[Metabolic syndrome X in women].

11210841

Lundon KM

2000

The effect of androstenedione/estrone supplementation on cortical and cancellous bone in the young intact female monkey: a model for the effects of polycystic ovarian disease on the skeleton?

11212071

Crosignani PG

2001

Polycystic ovarian disease: heritability and heterogeneity.

11213124

Liao WX

2001

Follicle-stimulating-hormone receptor and twinning.

11214949

Cibula D

2000

Multiple ovarian biopsy in the treatment of women with polycystic ovary syndrome (PCOS).

11218147

Fedorcs?k P

2000

Leptin and leptin binding activity in the preovulatory follicle of polycystic ovary syndrome patients.

11220168

Wakley G

2000

A Muslim woman with infertility.

11220291

Iuorno MJ

1999

The polycystic ovary syndrome: treatment with insulin sensitizing agents.

11223709

D'Amelio R

2001

Association between polycystic ovary and fibrocystic breast disease.

11226029

Trounson A

2001

Maturation of human oocytes in vitro and their developmental competence.

11228061

De Leo V

2000

Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.

11228062

Battaglia C

2000

Polycystic ovary syndrome: a new ultrasonographic and color Doppler pattern.

11228207

Villa P

2001

Effect of feeding on growth hormone response to growth hormone-releasing hormone in polycystic ovarian syndrome: relation with body weight and hyperinsulinism.

11228227

Cavilla JL

2001

The effects of meiosis activating sterol on in-vitro maturation and fertilization of human oocytes from stimulated and unstimulated ovaries.

11228228

Elting MW

2001

Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population.

11228476

Korhonen S

2001

Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.

11230277

Solomon CG

2001

Brief review: hypertension in pregnancy : a manifestation of the insulin resistance syndrome?

11230989

Lamminen T

2001

A common genetic variant of luteinizing hormone; relation to normal and aberrant pituitary-gonadal function.

11231980

Arslanian SA

2001

Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.

11231981

Veldhuis JD

2001

Disruption of the joint synchrony of luteinizing hormone, testosterone, and androstenedione secretion in adolescents with polycystic ovarian syndrome.

11232020

Welt CK

2001

Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles.

11232039

Tucci S

2001

Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus.

11235033

Slowey MJ

2001

Polycystic ovary syndrome: new perspective on an old problem.

11237218

Venkatesan AM

2001

Insulin resistance in polycystic ovary syndrome: progress and paradoxes.

11238496

Jakubowicz DJ

2001

Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome.

11238505

Fogel RB

2001

Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome.

11238527

Jakimiuk AJ

2001

Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries.

11238551

Nestler JE

2001

Metformin and the polycystic ovary syndrome.

11239531

Saleh A

2001

Effects of laparoscopic ovarian drilling on adrenal steroids in polycystic ovary syndrome patients with and without hyperinsulinemia.

11239532

Stadtmauer LA

2001

Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors.

11239549

Fernandez H

2001

Operative transvaginal hydrolaparoscopy for treatment of polycystic ovary syndrome: a new minimally invasive surgery.

11239554

Moran C

2001

Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome.

11242642

Mori M

2001

[Recent progress in epidemiologic research of uterine cancer].

11245645

Paradisi G

2001

Polycystic ovary syndrome is associated with endothelial dysfunction.

11252835

Wauters M

1999

Gender differences in leptin levels and physiology: a role for leptin in human reproduction.

11254018

Soares JC

2000

Valproate treatment and the risk of hyperandrogenism and polycystic ovaries.

11255689

Vasiljevi? M

2000

[The role of insulin and hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome].

11262358

Medina G

2000

[PPARgamma and thiazolidinediones, something more than a treatment for diabetes].

11262736

Bauer J

2001

Epilepsy therapy: issues for women and men.

11263206

Dong H

1999

[Application of gonadotropin-releasing hormone agonist for triggering ovulation in high risk gonadotropin stimulating cycles of infertile polycystic ovary syndrome patients].

11265665

Schachter M

2001

Hyperinsulinemia: not involved in the development of PCO?

11268559

Janeckov? R

2001

[New findings on the role of leptins in regulation of the reproductive system in humans].

11272062

Cibula D

2000

[Hyperandrogenic syndrome (polycystic ovary syndrome)--diagnostic criteria, differential diagnosis, clinical signs and laboratory findings (symptomatology), late risks].

11273567

Azziz R

2000

The Second International Symposium on the Developmental Aspects of Androgen Excess, Toronto, Canada, 20 June 2000.

11277552

Rao G

2001

Insulin resistance syndrome.

11278212

Balasch J

2001

Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.

11278215

Norman RJ

2001

Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome.

11278230

Michelmore KF

2001

Polycystic ovaries and eating disorders: Are they related?

11278997

Arlt W

2001

Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase.

11279294

Shalev E

2001

The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women.

11284649

Kovacs G

2001

The current status of polycystic ovary syndrome.

11285435

Sabogal JC

2001

Leptin in obstetrics and gynecology: a review.

11287026

Witchel SF

2001

Candidate gene analysis in premature pubarche and adolescent hyperandrogenism.

11287037

San Mill?n JL

2001

Role of the pentanucleotide (tttta)(n) polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism.

11292997

Lewis V

2001

Polycystic ovary syndrome. A diagnostic challenge.

11292998

Talbott EO

2001

Cardiovascular risk in women with polycystic ovary syndrome.

11292999

Zborowski JV

2001

Polycystic ovary syndrome, androgen excess, and the impact on bone.

11293000

Iuorno MJ

2001

Insulin-lowering drugs in polycystic ovary syndrome.

11293001

Phipps WR

2001

Polycystic ovary syndrome and ovulation induction.

11293002

Zacur HA

2001

Polycystic ovary syndrome, hyperandrogenism, and insulin resistance.